Dr. John D. Carmichael, MD

Dr. Carmichael practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Carmichael's NPI, 1396818241, was assigned on November 16, 2006. Dr. Carmichael graduated from VCU School of Medicine in 1998. Dr. Carmichael holds California license A92204.

Dr. Carmichael's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Carmichael's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Carmichael is also affiliated with USC Verdugo Hills Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Carmichael to 1 more group practice or clinic, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carmichael practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Carmichael's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Carmichael is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Carmichael's licenses on file in 3 states: California, Oklahoma and New York.

Dmand AI lists chronic diabetes, enlarged thyroid, fluid and electrolyte imbalances, parathyroid gland disorder, testicular dysfunction and underactive thyroid among the conditions Dr. Carmichael treats.

CMS data shows 226 Medicare services from Dr. Carmichael across 3 procedure codes in 2024, for 114 Medicare patients. Medicare paid $10,546 for them.

CMS counts 114 Medicare patients who saw Dr. Carmichael in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 42% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carmichael's median patient age at 51, with 58% women.

In 2024, Dr. Carmichael wrote 1,100 Medicare Part D claims for 111 patients. 72% of them were for generic drugs. CMS names the drug for 947 of them, across 17 drugs with 11 or more claims each, at $293,532 in total drug cost. In 2023, CMS named 864 claims across 16 drugs.

Dr. Carmichael accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carmichael as offering telehealth.

Dmand AI links 4 papers to Dr. Carmichael. Dr. Carmichael's most frequent co-authors are Vivien S. Bonert, MD, Alejandro R. Ayala, MD and Beverly M K Biller, MD.

CMS Open Payments shows 126 general payments to Dr. Carmichael from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Novo Nordisk Inc paid the most, $55,882. It also lists 19 research payments totaling $17,630 from 2016 to 2022.

Dmand AI lists 1 award for Dr. Carmichael, most recently CMS Stage 1 EHR in 2013.

Dr. Carmichael graduated from VCU School of Medicine in 1998. Dr. Carmichael is a member of AACE, ENDO and Pituitary Society.

Dr. Carmichael is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.